ZEALAND PHARMA A/S: Financial statements 2020
CVR: 20045078
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 353,314,000 and a net result of DKK -846,729,000 compared with DKK -571,541,000 the year before. That is an increase of 754.8% compared with the year before. The profit margin was -239.7%. Equity in the 2020 report amounted to DKK 1,229,311,000. The solvency ratio was 69.8%. The company had 297 employees in the financial year.
- Revenue
- DKK 353,314,000
- Gross Profit
- DKK 262,749,000
- Profit/Loss
- DKK -846,729,000
- Equity
- DKK 1,229,311,000
- Total Assets
- DKK 1,761,949,000
- Employees
- 297
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 353.3M | 262.7M | -846.7M | 1.2B | 297 |
| 2019 | 41.3M | - | -571.5M | 1.2B | - |
| 2018 | 38M | - | 581.3M | 1.1B | - |
| 2017 | 139.8M | - | -272.3M | 528.5M | - |
| 2016 | 234.8M | - | -153.9M | 278.2M | - |
Official annual report
How creditworthy is ZEALAND PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 to June 30, 2020.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 to March 31, 2020.
ZEALAND PHARMA A/S has published its annual report for 2019. Revenue came to DKK 41,333,000, and the net result was DKK -571,541,000.
As of April 2, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZEALAND PHARMA A/S.
As of April 2, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZEALAND PHARMA A/S.
As of April 2, 2020, Gertrud Koefoed Rasmussen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Jacob Ulrik Fog has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Nikolaj Frederik Beck has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Iben Louise Gjelstrup has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Hanne Heidenheim Bak has left the board of directors of ZEALAND PHARMA A/S.
About ZEALAND PHARMA A/S
ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.
